Skip to content

A prospective multicenter clinical study in the treatment of patients with hemifacial spasm is invalid after MVD

A prospective multicenter clinical study in the treatment of patients with hemifacial spasm is invalid after MVD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007435
Enrollment
Unknown
Registered
2015-11-22
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemifacial spasm

Interventions

The group of Re operation in the short term: Re-do microvascular decompression operation
The group of Conservative treatment:Conservative treatment

Sponsors

Xinhua Hospital Affiliated to Medicine School of Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Unilateral of hemifacial spasm; (2) 20 years old <age<70 years old; (3) MVD operation for the first time; (4) hemifacial spasm is invalid after MVD.

Exclusion criteria

Exclusion criteria: (1) Secondary hemifacial spasm; (2) Facial nerve was combined in the first MVD operation; (3) Treatment with botulinum toxin has been implemented preoperative; (4) Patients have poor compliance; (5) Patients with serious complications after the first MVD operation : facial paralysis, cerebrospinal fluid leakage, intracranial hematoma, etc.

Design outcomes

Primary

MeasureTime frame
The degree of symptom relief of postoperation;The function of facial nerve;Hearing;The quality of life;Other complications of postoperation;

Countries

China

Contacts

Public ContactShi-ting Li
lsting66@163.com+86 021-25078001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026